Literature DB >> 34064212

Physicochemical Characterization Cascade of Nanoadjuvant-Antigen Systems for Improving Vaccines.

Giuditta Guerrini1, Antonio Vivi1, Sabrina Gioria2, Jessica Ponti2, Davide Magrì2, Arnd Hoeveler2, Donata Medaglini1, Luigi Calzolai2.   

Abstract

Adjuvants have been used for decades to enhance the immune response to vaccines, in particular for the subunit-based adjuvants. Physicochemical properties of the adjuvant-protein antigen complexes, such as size, morphology, protein structure and binding, influence the overall efficacy and safety of the vaccine. Here we show how to perform an accurate physicochemical characterization of the nanoaluminum-ovalbumin complex. Using a combination of existing techniques, we developed a multi-staged characterization strategy based on measurements of increased complexity. This characterization cascade has the advantage of being very flexible and easily adaptable to any adjuvant-protein antigen combinations. It will contribute to control the quality of antigen-adjuvant complexes and immunological outcomes, ultimately leading to improved vaccines.

Entities:  

Keywords:  adjuvants; antigens; characterization; vaccines

Year:  2021        PMID: 34064212     DOI: 10.3390/vaccines9060544

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  31 in total

1.  Measuring protein structure and stability of protein-nanoparticle systems with synchrotron radiation circular dichroism.

Authors:  Stefania Laera; Giacomo Ceccone; Francois Rossi; Douglas Gilliland; Rohanah Hussain; Giuliano Siligardi; Luigi Calzolai
Journal:  Nano Lett       Date:  2011-09-28       Impact factor: 11.189

2.  Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation.

Authors:  Zhou J Deng; Mingtao Liang; Michael Monteiro; Istvan Toth; Rodney F Minchin
Journal:  Nat Nanotechnol       Date:  2010-12-19       Impact factor: 39.213

3.  Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against Streptococcus pneumoniae.

Authors:  Vidyashankara Iyer; Lei Hu; Mangala Roshan Liyanage; Reza Esfandiary; Christoph Reinisch; Andreas Meinke; Jeff Maisonneuve; David B Volkin; Sangeeta B Joshi; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2012-04-26       Impact factor: 3.534

Review 4.  Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities.

Authors:  Fatemeh Farjadian; Amir Ghasemi; Omid Gohari; Amir Roointan; Mahdi Karimi; Michael R Hamblin
Journal:  Nanomedicine (Lond)       Date:  2018-11-19       Impact factor: 5.307

5.  Oral tolerance to ovalbumin in mice as a model for detecting modulators of the immunologic tolerance to a specific antigen.

Authors:  J H Kim; M Ohsawa
Journal:  Biol Pharm Bull       Date:  1995-06       Impact factor: 2.233

6.  Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens.

Authors:  LaToya S Jones; Laura J Peek; Jonathan Power; Aaron Markham; Brian Yazzie; C Russell Middaugh
Journal:  J Biol Chem       Date:  2005-01-31       Impact factor: 5.157

Review 7.  Structure and enzymatic activities of human serum albumin.

Authors:  Yu Wang; Shihua Wang; Mingdong Huang
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

8.  Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants.

Authors:  Anna Sokolovska; Stanley L Hem; Harm HogenEsch
Journal:  Vaccine       Date:  2007-04-19       Impact factor: 3.641

Review 9.  Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want.

Authors:  Harm HogenEsch; Derek T O'Hagan; Christopher B Fox
Journal:  NPJ Vaccines       Date:  2018-10-10       Impact factor: 7.344

10.  Mechanism of immunopotentiation and safety of aluminum adjuvants.

Authors:  Harm Hogenesch
Journal:  Front Immunol       Date:  2013-01-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.